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Development of an Implantable System to Measure the Pressure-
Volume Relationship in Ambulatory Rodent Hearts 
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The design, fabrication, and in-vivo testing of an implantable device to measure 
the pressure-volume (PV) relationship in the hearts of conscious, untethered rats is 
presented.  Volume is measured using a tetrapolar catheter positioned in the left-ventricle 
which emits a 20kHz current field across the LV blood pool and parallel heart tissue and 
measures the resulting voltage.  The admittance method is used to instantaneously 
remove the contribution of the parallel heart muscle and Wei’s non-linear blood 
conductance-to-volume equation is used to calculate volume.  Pressure is measured with 
a strain gauge sensor at the tip of the catheter.  The implant was designed to be small, 
light, and low-power.  An average implant occupies 5 cm
3
, weighs 8g, and on a single 
charge collects data for 2 months taking 43 samples per day.  Collected data is 
transmitted wirelessly via RF to a base station where it is recorded.  The functionality of 
the implant and measurement system was verified in six rat experiments.  In all 
experiments, ambulatory PV loops were measured on implantation day.  Viable pressure 
data was recorded for 11 days in one rat; in another rat viable admittance data was 
collected for 10 days.  Changing catheter position and non-constant blood resistivity are 
considered as sources of error in the volume measurement. Pressure drift due to changing 
atmospheric pressure is considered as a source of error in the pressure measurement.  
Lastly, alternative uses for the implant and directions for future improvement are 
considered. 
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Chapter 1: Introduction 
1.1 MOTIVATION 
With advances in the development of transgenic rodents, murine models of 
cardiac pathology have become available for pharmaceutical studies [1].  To accurately 
assess the efficacy of medical interventions on these animals, a device is needed that can 
report measures of cardiac health in ambulatory rodents long term.   The goal of this 
work is to develop such a device.  
The pressure-volume relationship is an important indicator of cardiac health.   
Pressure is relatively easy to measure with cannulation, or more recently, solid state 
pressure sensors.  Obtaining an accurate measure of volume, however, can be 
challenging.  The gold standard in volume measurement is MRI [2], though ultrasound 
can be used as well.  These techniques are expensive and require the animal to be 
anesthetized.  An alternative method is to derive the volume of the left ventricle (LV) 
from the varying electrical properties of the heart.  In 1981, the first cardiac catheter was 
developed to measure the impedance of the blood pool in the LV [3].  This, and 
subsequent cardiac catheters carry electrodes that emit an electric field and measure the 
response of the blood pool.  Sagawa et al. were the first to show that the conductance 
measured from an LV catheter was proportional to LV volume in 1985 [4].  With new, 
smaller catheter technology, the first PV loops in mice were measured in 1998 [5].  Since 
then, research has focused on finding the most accurate calibration scheme for converting 
blood conductance to volume [6, 7, 8]. 
 2 
But there is still work to be done if PV data is to be measured from ambulatory 
rats in chronic studies.  Calibration methods must consider how variables such as catheter 
position, blood conductivity, and electrode impedance change over time and 
measurement devices should be small, low-power, and physically robust.  In the 
literature, two studies (Uemura, 2004 and Raghavan, 2011) have shown the feasibility of 
telemetric PV rat systems for chronic studies. The Uemura device was fully implantable, 
consisted of a 14g/11cm
3
 processor transmitter, a 12g/10 cm
3
 battery, lasted 8 days, and 
produced consistent data in rats over a 6-day span [9].  The Raghavan device was a 27g 
backpack system interfaced to an implanted catheter that lasted 24 hours and produced 
telemetric PV data every 2 minutes for 6 rats [10].  This work is an extension of 
Raghavan’s work and the second iteration of the Shuhatovitch device [11], a fully 
implantable PV measurement system that improves implant size to 8g/5 cm
3
 and lifetime 
to over 2 months.   
1.2 SIMILAR DEVICES 
There are several companies that produce implants to measure biological signals 
in animals.  Implant manufacturers and the biological parameters they are capable of 
measuring are listed in Table 1. Note that the experimental UT Austin implant is the only 





Table 1: Market Analysis of Competitive Devices 




   
Size 5-6 cm
3







Battery Life Inductive Power 2-6 weeks 
continuous, 
6mo. Low pwr. 



















Pressure Range -20 to 300 
mmHg 
-50 to 300 
mmHg 
-20 to 300 
mmHg 




   0.4 mmHg 
Pressure Accuracy   +/- 3 mmHg  
Pressure Drift   <2 
mmHg/mo. 
± 3 mmHg 
Sampling 
Frequency 








Inductive RF RF RF 
 
1.3 DESIGN OBJECTIVES 
The goal for this project is to develop an implant capable of measuring PV 
relationships in ambulatory rats.  Objectives for the design are listed in Table 2.  In this 
application, size and weight are of utmost concern.  The target weight of the design was 




, to be reasonably competitive with similar commercial devices and improve 
upon previous experimental devices. 
Table 2: Design Goals 
1 < 5 cm
3
 total volume 
2 < 25 g weight 
3 < 1 mmHg pressure resolution 
4 >  350 mmHg pressure range 
5 200-2000 Ω impedance range 
6 Reasonably robust interface to the delicate catheter 
7 Waterproof and biocompatible 
8 Transmit data wirelessly 
9 2 month battery life sampling at least once per day 
  
Consulting with veterinarians and animal surgeons, a system concept was 
developed in which the implant would be placed under the skin between the rat’s 
shoulder blades.  The catheter would then wrap around the rats shoulder, beneath the 
skin, and be inserted into the LV through the carotid artery.  The rat would be placed near 
a base station where PV data would be periodically collected and displayed.  This system 
concept is shown in Figure 1. 
 
Figure 1. System Concept 
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1.4 ADMITTANCE METHOD 
The implant interfaces to a 1.9F Scisense Pebax catheter (Figure 2) that contains 
four electrodes and a pressure sensor.  A 4-electrode configuration is generally 
considered to be superior to a 2-electrode configuration for plethysmographic 
measurements because separation of the current production and voltage measurement 
electrodes leads to a more uniform electric field in the voltage sensing region.  In a 2-
electrode system, the current density is higher near the electrodes, causing the tissue 
impedance near the electrodes to be weighted more heavily [12]. 
In this application, a 20kHz current field is emitted from the outer 2 electrodes, 
and a potential difference is measured at the inner electrodes.  The voltage measured 
from the inner electrodes differs in magnitude and phase from the excitation signal, and 
thus provides a value for complex admittance.   
 
Figure 2: Scisense PV Catheter (right), and Catheter Positioning (left). 
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This complex admittance value represents a measurement of the bulk properties 
of the catheter and the tissue surrounding the catheter, namely, the blood in the left 
ventricle (LV) and the surrounding heart muscle.  Since the volume of the LV is 
proportional to the conductance of the blood alone, the admittance of the muscle is 
unwanted signal and must be removed.  The bulk admittance signal measured by the 
circuit can be represented as the sum of the blood conductance (Gb), muscle conductance 
(Gm), muscle susceptance (Bm = jωCm), and catheter susceptance (Bprobe = jωCprobe) as 
given in ( 1 ). 
                           
( 1 ) 
Cprobe is the parasitic capacitance of the catheter due to the length of the catheter 
and the close proximity of the four electrode wires within the catheter lumen.  This value 
is dependent on load conductance and is estimated from a one-time saline calibration.  
After calibrating the bulk data for Cprobe, the remaining imaginary component in Ymeas 
should be solely related to Cm.  Note, however, that representing the lumped ImY error of 
the probe as a single capacitor is based on an assumed equivalent circuit for the catheter 
that may not include all important effects of the physical probe.  Calibration for probe 
effects is explained in more detail in Chapter 4. 
From general principles, conductance, G with units [S] and capacitance, C, with 
units [F] in a homogeneous medium can be written as in ( 2 ) and ( 3 ), respectively. 




∬    
 ∫    
    ( 2 ) 
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∬    
 ∫    
    ( 3 ) 
Here, F represents the geometric form factor common to both equations.  With this, it is 
clear that conductance and capacitance in the same geometry are related as in ( 4 ), where 
σ is conductivity [S/m] and ε is permittivity [F/m].  From this, the conductance of the 








( 4 ) 
    
 
 
   
( 5 ) 
It follows that: 
      {     }  
 
 
   
( 6 ) 
where the sigma-epsilon ratio (σ/ε) represents the ratio of the conductance of the muscle 
to the permittivity of the muscle and allows the removal of the muscle conductance from 
the bulk measured conductance to derive blood conductance.   
In the 1980’s, Baan et al. developed a linear equation to convert blood 
conductance, Gb [S] to volume, V [cm
3
], according to equation ( 7 ). 
   
 
 
      
( 7 ) 
where ρ is blood resistivity [Ω-cm], L [cm] is the distance between the measuring 
electrodes, and α is an empirically-derived field geometry correction factor.  This 
equation assumes a uniform electric field in the measurement volume, an unrealistic 
assumption given the non-uniform geometry of the heart.  In 2005, Wei et al. extended 
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this equation to include a non-linear correction factor, γ, that forces the calculated stroke 
volume (SV) to equal the stroke volume measured during calibration [6] ( 8 ). 
   
 
      
      
( 8 ) 
Gamma is specified as the larger positive solution to the quadratic equation dependent on 
stroke volume, SV [cm
3
] and blood conductance at end systole (Gb-ES [S]) and end 
diastole (Gb-ED [S]) as described in ( 9 ). 
   
   √      
  
          
        (           )                     
      (           )                             
    (     )(     )                                   




Chapter 2.  Implementation 
2.1 SYSTEM 
Figure 3 is a diagram of the measurement system.  The implant periodically 
collects PV data and transmits it wirelessly to a base station, which consists of the access 
point, computer, and display.  Once PV data is received at the access point, it is relayed 
to the computer where it is recorded and displayed via a LabVIEW interface.  
Communication can occur in the reverse direction as well.  Commands and settings 
indicated by the user are sent over USB to the access point where they are subsequently 
transmitted to the implant by RF during a communication period. 
 
Figure 3: System Block Diagram 
2.2 IMPLANT HARDWARE 
The implant contains four main hardware blocks: admittance measurement, 
pressure measurement, RF communication, and power management as shown in Figure 4.  
A photograph of the implant circuit is provided in Figure 5. 
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Figure 4. Implant Hardware Block Diagram 
            









2.2.1 Admittance Block 
The admittance and pressure measurement blocks make up the bulk of the analog 
circuitry.  To measure admittance, a load-independent, active current source is used to 
supply 30 µA, 20 kHz sinusoidal excitation across electrodes 1 and 4 of the catheter.  
With a constant current source, the voltage across the bulk admittance of the heart around 
the catheter varies according to Ohm’s law (Y = I/V).  This differential voltage is 
measured across electrodes 2 and 3, amplified and filtered, and sampled by at 10-bit 
resolution by the microcontroller for processing.  Experimentation has shown that the 
typical resistance of the blood pool in a rat LV is around 800 to1200 Ω.  Figure 6 
describes the linearity and Figure 7 the noise characteristics of the admittance channel.  
Notice that the largest real Z residual for a linear fit is 3.2 Ω, and the largest imaginary Z 
residual is 0.4 Ω.  Considering the measurement range of 200 to 2000Ω, the admittance 
channel is linear within 0.2%.     
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Figure 6: Admittance Block Linearity 
 
Figure 7: Admittance Block Noise 
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2.2.2 Pressure Block 
A schematic of the Scisense pressure transducer is given in Figure 8.  Two solid 
state resistors are positioned orthogonally to one another on a cantilever beam that is 
placed beneath an opening in the catheter referred to as the pressure window.  A flexible 
seal isolates the lumen of the catheter from the blood pool such that the deflection of the 
cantilever beam is relative to the pressure difference between the blood pool and the 
catheter lumen.   
 
Figure 8: Pressure Transducer 
As the catheter deflects downward, the stripes of R1 become longer and the stripes 
of R2 become wider, thereby increasing R1 and decreasing R2 according to ( 10 ). 




( 10 ) 
Where ρ is the resistivity of the stripe [Ω-m], L the length [m], and A the cross-sectional 
area [m
2
].  To measure pressure, R1 and R2 from the catheter are used as the bottom 
elements in a Wheatstone bridge circuit.  The bridge contains a digital balancing 
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potentiometer controllable through the LabVIEW interface.  The differential output of the 
Wheatstone bridge is amplified and filtered, then sampled by a 10-bit ADC on the 
microcontroller.  
Let us derive the sensitivity of the pressure transducer and measurement circuitry.  
Figure 9 below shows the Wheatstone bridge circuit. 
 
Figure 9: Pressure Measurement Circuitry 
The output voltage of the INA is, 
              (
  
        
 
  
     
) ( 11 ) 
Here R5 is the digital balancing potentiometer.  Assuming R1 = R2 = RB and R4+R5 = R3 
= RT, we can represent a small and equal but opposite change in each RB as ΔR and 
equation ( 11 ) reduces to equation ( 12 ). 
              (
     
(     )     
) ( 12 ) 






              (
     
(     ) 
)               (     )
      ( 13 ) 
Sensitivity is then defined by the derivative of Vout with respect to ΔR. 
 
     
   
         (
   
(     ) 
)   ( 14 ) 
With this transfer function and calibration results, the sensitivity of the Scisense 
pressure transducer is calculated.  Using a Scisense pressure measurement box as a 
standard, the output of the pressure circuit on the implant was observed to traverse 232 
ADC codes per 100 mmHg.  The 10-bit ADC uses a reference of 2.5 V, and thus has a 
resolution of 2.5V/1024 codes.  As calculated above, the sensitivity of the pressure circuit 
to ΔR is 0.198 V/Ω.  Thus, the sensitivity of the pressure transducer, in terms of 
Ω/mmHg, is: 
 (
         
       
)(
     
          
) (
  
       
)  
      
     
 ( 15 ) 
The same data indicates that the ADC-limited resolution of the pressure channel is 
100mmHg/232codes = 0.43mmHg/code.  Given that this is a 10-bit ADC, this resolution 
translates to a total measurement range of 440 mmHg.  Figure 10 shows the output of the 
pressure channel for a 0 mmHg atmosphere-relative pressure.  The RMS value of the 
noise is 0.306 mmHg, which is less than the ADC-limited resolution.  This indicates that 
> 68% (±1σ) of the pressure measurements fall within 1 ADC code of the mean, a 
conclusion that is clearly visible in the figure. 
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Figure 10: Pressure Channel Output for 0mmHg Relative Pressure Input 
2.2.3 RF Block 
The RF communication functionality of the implant is implemented mainly by the 
microcontroller.  With the correct arrangement of accessory components, the MCU 
outputs a 915 MHz, differential RF signal.  A balun is used to convert this differential 
signal to a single-ended signal that is capacitively coupled to an antenna.   
The MCU has a software-tunable output power level and variable output data rate.  
Fast data rates reduce transmission time, which reduces the communication range and the 
total power of each transmission.  For this implementation, it was found that setting the 
RF output level to 0dbm (maximum) and the baud rate to a moderate 174 kBaud provided 
a typical communication range of 15 feet.  During implantation and data collection the 
circuit is within ~10 feet of the base station, so the output power level is sufficient 
without being wasteful.   
The communication range is affected by the orientation of the transmitter antenna 
in relation to the receiver, the material surrounding the transmitter, and the presence of 
barriers or conductive bodies in the communication channel.  The received signal 





















strength indicator, or RSSI, is measured in decibels by the access point.  Figure 11 shows 
the RSSI from the implant to the access point under different conditions.   
 
Figure 11: RSSI Tests Under Different Conditions 
Encapsulating the circuit for implantation involves positioning a battery close to 
the antenna and applying layers of waterproofing.  In the first panel of Figure 11, a ~10 
dB drop in RSSI is observed for these modifications.  To model the effects of implanting 
the circuit in a conductive body (the rat), an encapsulated implant was submerged by 2 
mm in 200 mL of 3000μS/cm saline solution.  The second plot in Figure 11 shows a 7 dB 
Encapsulation Effect: 
encapsulated vs. non-
encapsulated implant in air, 
perpendicular to the receiver,  
at 2 feet. 
Saline Barrier: air surroundings 
vs. 3000μS/cm saline 
surroundings for an 
encapsulated implant, 
perpendicular to the receiver,  
at 10 feet. 
Orientation change: antennas 
parallel vs. antennas 
perpendicular for encapsulated 
implant in air,  









drop in RSSI for this effect.  In the standard system setup, the access point antenna is 
oriented perpendicular to the earth and the implant antenna parallel to the earth (flat on 
the rat’s back).  Changes in the implant position with movement of the rat may only 
improve the RSSI from the standard position as parallel antennas give the best RSSI as 
shown in the third plot in Figure 11. 
2.2.4 Power Management Block 
Low power consumption is implemented by two means: sleep functionality in the 
MCU and power gating of the analog circuitry.  The MCU used in this design has several 
sleep modes with differing power consumption.  For this application, the lowest power 
mode for which timing functionality was still available was chosen.  This LPM is 
specified to reach ~2µA, quiescent current consumption, a number verified on the bench.  
To ensure low power consumption for the implant as a whole, a MCU-controlled 
MOSFET is used to disable power to the analog circuitry during sleep.  Thus, only the 
essential sleep counter function in the MCU is enabled during sleep mode. 
2.3 IMPLANT SOFTWARE 
2.3.1 Main Functions 
The implant software is responsible for timing data collection events, packetizing 
and transmitting PV data, receiving and interpreting access point (AP) commands, and 
managing sleep/wake cycles.  The basic series of events executed by the implant is 
illustrated in Figure 12.  The colored middle segment represents the chain of events that 
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constitute one data collection.  That is, the circuit wakes up, enables the analog circuitry, 
collects a user-specified number of PV samples, packetizes and transmits the PV data via 
RF, then listens for new commands sent from the access point.   
 
Figure 12: Implant Software Flow Chart 
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2.3.2 Data Packet Format 
There are four main types of data packets that are used to communicate between 
LabVIEW and the implant.  The first two packet types, the control frame and data frame, 
are sent from the implant to the access point.  The second two packet types communicate 
settings and calibration constants from LabVIEW to the implant.   
 Each packet type has an ID as the first element.  This ID dictates how the 
remainder of the packet should be interpreted (first nibble).  The ID field also encodes the 
implant number (second nibble) so that LabVIEW can parse incoming data from multiple 
implants into the appropriate files.    
 
Figure 13: Data Packet Formats 
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2.4 POWER CONSUMPTION AND IMPLANT LIFETIME 
Plotting the instantaneous current draw versus time for the implant during a 
collection period allows us to estimate the energy “cost” of each data epoch (Figure 14).  
In a typical data epoch, 384 samples are collected at a 1 kHz sampling rate to give 384 
ms of data, about 1.5 – 2 cardiac cycles in the rat heart.  From Figure 14 we can see that 
the listening period is the most costly segment.  In bench testing it was observed that 4 
seconds of listening were necessary to ensure proper data transmission, but this figure 
could possibly be improved if a more robust handshake protocol were implemented such 




Figure 14: Current Consumption Profile 
By measuring the sleep current of the implant and the energy used per epoch, one 
can estimate the lifetime of the implant according to the following formula ( 16 ). 
                                              
( 16 ) 
Here t is the time in days, N the number of collection periods per day, Isleep the 
sleep current of the implant in mA, Ecollect the energy required for one measurement 
epoch, Ebattery the total energy in the charged battery, and Eremaining is the energy left in 
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the battery after time t.  All energy figures have units of mA-h. To calculate the lifetime, 
Eremaining is set to zero and find ( 17 ).   
           
        
                    
 ( 17 ) 
This formula assumes that Isleep amount of current is drawn constantly (even 
during collection).  This simplifies the formula and is a fair assumption given that Icollect  
>> Isleep and Isleep is within the uncertainty of the Icollect measurement method (explained in 
Section 3.4.2. 
The sleep current of a typical implant is in the range 1-5 µA.  Using a worst-case 
sleep current figure of 5 µA, a battery life of 150 mA-h, and a collection energy value of 
30.8 μA-h as calculated above, the estimated lifetime of the implant as a function of 
sampling epoch frequency is shown in Figure 15 (green line). 
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Figure 15: Lifetime Estimation 
When real lifetime points were measured, actual implant lifetime was found to be 
less than originally predicted.  This is a result of inefficiency in the battery, and 
underestimation of the sleep and measurement current.  The three red points in Figure 15 
indicate the results from bench testing trials.  Using MATLAB, Isleep and Ecollect from ( 16 
) were adjusted to minimize the error between the predicted curve (blue) and the 
measured points.  This process increased Ecollect by a factor of 1.5 from 30.8 μA-h to 46.0 
μA-h.  Isleep was increased by 2.9 from 5 μA to 14.7 μA.  Based on separate testing of the 
LiPo batteries, Ebat was decreased by 10% to 135 μA-h.   Figure 15 is annotated with 
markers to indicate 2 months and 30 minute cycle delay.  The evidence-based lifetime 
prediction suggests that the implant will last for 2 months collecting 43 samples/day.  If 






















































2.5 USER INTERFACE 
2.5.1. User interface hardware: Access Point 
The access point was implemented from a commercially available RF 
development board modified to communicate with LabVIEW through USB.  The access 
point performs minimal processing on the data sent from the implant.  Its purpose is 
mainly to intercept RF data and shuttle it to the computer via USB. 
2.5.2. User interface software: LabVIEW 
The LabVIEW interface serves two main functions, to store raw data in text files 
and to display incoming data in real time.  This interface is organized as three sets of 
tabular objects.  The largest tab set (left side of the screen) is used to display incoming 
data in different formats.  The two smaller tab sets are used to send commands and 
calibration constants to the implant (top tab set) and to monitor messages and RSSI from 
the implant (bottom tab set).   
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Figure 16: Fullscreen LabVIEW Interface 
Figure 17 shows the “Calibration” and “Run-Time Controls” tabs in more detail.  
To change epoch collection settings from the “Run-Time Controls” tab, variables are 
adjusted at the right-most side of the tab.  Pressing the large green “Start” button puts the 
specified settings in the access point queue to be sent the next time the implant awakens 
and issues a “CTS” (“Clear To Send”) message, which is displayed on the “Event Log” 
tab.  The implant or the access point can also be reset from LabVIEW by pressing the red 
“Implant” or “AP” buttons.  However, one must wait for the implant to issue a “CTS” 
before the circuit can be reset by software.  The “Run Delay” button activates a delay 
module in the main LabVIEW processing loop to conserve CPU processing cycles.  
During implantation, this run delay is inactivated so that data buffers don’t overflow. 
The calibration tab has two main segments for pressure and volume.  In the 
pressure segment, the “Pressure HW Offset” variable controls the digital potentiometer 
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on the implant.  Changing this value puts the new potentiometer wiper position in the 
access point queue (8 bit wiper register gives 255 positions).  This hardware offset must 
be correctly adjusted to bring the pressure into rage at the beginning of any experiment.  
The remaining variables on this tab apply a nominal gain, offset, and phase (for 
admittance data) for data representation in LabVIEW only.  Raw, uncalibrated data is 
recorded in the output text files.  This scheme allows the user to determine if the 
incoming data is reasonable based on previous calibrations, but still provides flexibility 
for precise calibration from raw files. A list of each LabVIEW control and its 
corresponding nominal value and range is presented in Table 3. 
 
   








Table 3: LabVIEW Interface Variables 





Number of samples 384 1 to 384 
Sampling period [ms] 1   ≥ 1 
Radio RX period [s] 2 ≥ 1 
Radio RX time [s] 4 ≥ 1 
Settling Cycles 3 ≥ 0 





Pressure Gain 0.43 Double value 
Pressure Offset 300 0 to 1024 
Pressure HW Offset 130 0 to 255 
Volume Gain Offset 0 Double value 
Volume Gain Slope 1.7 Double value 
Volume  
Phase Offset [rad] 




Chapter 3: Implant Manufacturing  
The physical assembly of the implant is one of the most challenging aspects of 
this project.  The catheter is very delicate and a series of heating, gluing, and sealing 
procedures introduce the potential for damage.    
There are several design requirements that are addressed in the assembly of the 
implant.  The cavity where the implant is placed between the rat’s shoulder blades is 
dynamic, so the implant assembly should allow for motion of the catheter.  If the catheter 
is bent at too sharp of an angle, it can kink and break the wires inside.  The rat is flexible 
and can nearly reach the implantation site, so the battery charging interface should be as 
small as possible.  To prevent adverse tissue reaction, the implant should be 
biocompatible.  Finally, the circuit must be sealed against moisture. 
3.1 ATTACHING THE CATHETER 
The shape of the ambulatory rat can be seen as a continuum between two 
positional extremes: hunched and elongated.  Since the catheter is positioned along the 
long axis of the rat, lateral motion of the catheter along the long axis of the implant 
should be accounted for.  To do this, the catheter is formed with a 180° bend as shown in 
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Figure 18. Figure 18 shows the shape of the catheter over a 2.5 cm lateral displacement. 
 
Figure 18: Displacement of Catheter Along Long Axis 
The catheter is formed by gentle heating with a hot air gun.  A ceramic mold was 
created to hold the catheter in place during heating to reliably produce the desired bend.  
In the final implant assembly the battery is placed directly over the circuit, and the 
catheter is attached to the inward-facing side of the circuit, so the bending mold includes 
one sloped side near the attachment point of the catheter to account for the width of the 
battery.  This allows the formed catheter to lie just on top of the battery in the finished 
implant. 
The catheter is electrically connected to the circuit by direct soldering.  The 
footprint of the catheter connection point in the circuit is that of a 2x4 8-pin, 50mil 
x = 0  x = -0.5 
cm 
x = 2.0 
cm 
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connector, so test loads may be applied to for calibration.  An illustrated procedure for 
attaching the catheter to the implant circuit can be found in Appendix A. 
3.2 BATTERY CONSIDERATIONS 
The implant uses a lithium polymer battery from www.powerstream.com.  LiPo 
batteries are available in a variety of form factors, with batteries approximating the size 
of the implant circuit having capacities in the range 40-150 mA-hr.  The battery used in 
most of the implants is a 130 mA-hr battery with a volume of 4x12x35 mm or 1.68 cm
3
, 
and a weight of 2.3g. 
These batteries are relatively inexpensive and capable of failure.  For this reason, 
each battery was tested through a charging/discharging procedure to ensure functionality 
and verify the energy capacity. Each battery was charged using a LiPo battery charger 
delivering a maximum current of 0.1 A (minimum setting).  Average charging times for 
viable batteries were about 75 minutes.  Some dysfunctional batteries were identified due 
to shorter charging times.  With full charge, a test discharge was performed across a 
resistor such that the battery delivered 100 mA on average.  A trace for discharge current 
over time was recorded and the area under this curve was calculated to get a measure of 
total energy delivered on one charge.  Ten viable 130 mA-hr batteries were tested and 
found to achieve 91.2±3.2% efficiency (n=10).  Three 150 mA-hr batteries were tested 
and found to achieve 88.5±3.2% efficiency (n=3). 
During implantation of the circuit, PV data must be transmitted nearly 
continuously as the pressure signal is used to determine when the catheter passes from the 
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aorta into the LV.  A typical implantation can take about an hour, draining the battery at 
this fast collection rate.  To improve the lifetime of the battery after implantation, power 
and ground leads are externalized so that the battery can be recharged.  Several iterations 
of a battery charging connector were attempted as described in Section 3.5.   
3.3 SEALING THE CIRCUIT 
The implant must be sufficiently sealed for biocompatibility and reliability of the 
circuit.  There are three basic layers of encapsulation over the circuit.  3M DP-270 epoxy 
potting compound is applied directly to the circuit to provide basic waterproofing.  This 
ensures that any moisture trapped inside the implant during manufacture, or introduced 
after surgery does not create parallel conductive paths on the circuit.   The potting 
compound is also used to glue the battery to the circuit.   
Electrical tape is used to create a smooth surface over which silicone can be 
applied.  This improves uniformity of the hand-applied silicone layer.  The electrical tape 
also allows for the implants to be different colors, a feature that provides a quick 
identification method. 
Dow Corning 734 flowable sealant is used as the final sealant layer.  This silicone 
is biologically inert and provides the outer layer of protection against moisture.   
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3.4 BENCH TESTING AND CALIBRATION 
3.4.1 Test Loads Before Catheter Attachment 
Test loads are applied before attaching the catheter to the implant circuit to ensure 
that the circuitry is functional.  A resistor switchbox is used to sweep a resistive load to 
the circuit from 200 to 2000Ω in 100Ω steps.  Next, a capacitor switchbox in parallel with 
a 1000Ω resistor is used to sweep the load through the impedances 1000Ω || (4nF, 10nF, 
20nF, 30nF, 40nF).  The parallel resistance is necessary for the capacitor sweep because 
the current source has difficulty driving a purely capacitive load.  The resistor and 
capacitor sweep are used to determine the phase offset of the admittance measurement 
circuitry.  During calibration, phase offset is adjusted until the imaginary component of 
the resistor sweep is minimized.  Gain may also be applied to the signal such that the real 
component of the resistor sweep matches the nominal value set. 
A test catheter fitted with an 8-pin connector is used to verify that the pressure 
measurement circuitry is functional.  The sensor end of the test catheter is placed in a 
closed, saline-filled pressure chamber with an attached syringe.  The digital balancing 
potentiometer in the pressure circuit is controlled through the “Pressure HW Offset” 
variable in LabVIEW.  This value is adjusted until the pressure signal comes into range.  
Slight force applied to the syringe plunger ensures that the analog circuitry is functional. 
3.4.2 Test Loads After Catheter Attachment 
After the permanent measurement catheter is attached to the circuit, saline 
calibration data is collected so that probe capacitance may be removed.  The catheter is 
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introduced to a series of large saline containers approximating infinite conducting 
mediums with conductivity values of 1000, 2000, 3000, 6000, 8000, 11000 μS/cm.   
The pressure hardware offset for the measurement catheter is determined as 
before, by varying the digital potentiometer value through LabVIEW until the signal 
comes into range.  Pressure gain is determined using a Scisense pressure measurement 
system as truth.  A test catheter interfaced to the Scisense box is placed in the same 
pressure chamber as the measurement catheter (attached to the circuit).  ADC output 
values from the implant pressure circuit at 0 and 100 mmHg are recorded and used to 
calculate pressure gain. 
Current consumption during sleep and data collection is measured for each 
implant as well.  A Fluke multimeter with a μA range setting is used to measure the sleep 
current, which is typically in the 1-5μA range.  The circuit shown in Figure 19 is used to 
provide a trace of current consumption versus time during a data epoch.  This data is used 
to estimate implant battery life as described in Section 2.4.   
 
Figure 19: Supply Current Measurement Circuit 
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3.5 EVOLUTION OF THE IMPLANT 
3.5.1 Implant Version 1 
In the first fully implanted system, the catheter was made to be detachable so that 
the circuit could be reused.  Eight 30-guage wires left the implant and connected to the 
2x4 8-pin 50-mil connector.  The catheter was attached to the complementary connector 
and the interface was sealed with silicone.  Power and ground were on two of the 
connector pins and the procedure for recharging included opening the rat’s dorsal incision 
to expose the circuit, disconnecting the catheter, connecting the battery charger and 
charging the circuit, then reconnecting the catheter.  It was found that the connectors 
were too small and slippery (after implantation) for this to be a feasible option.  What’s 
more, the 8-wires exiting the implant proved hard to seal appropriately, and liquid seeped 
into the circuit at the catheter interface between the wires. 
 
Figure 20: Version 1 Implant 
3.5.2 Implant Version 2 
In the next iteration of the implant, the catheter was attached directly to the circuit 
and two wires for charging were soldered to the same 8-pin connector as before (4-pins 
per wire for stability).  Two implants were constructed in this manner, and in both 
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experiments the rats removed the battery connector by scratching.  Post-mortem 
evaluation of the implant showed that the circuit was mostly moisture-free, though some 
of the pins of the microcontroller were slightly corroded. 
 
Figure 21: Version 2 Implant 
3.5.3 Implant Version 3 
In the latest implant revision to date, the catheter is directly attached to the circuit 
as in version 2, but the battery connector simply consists of two wires sealed together 
with silicone.  The power wire is longer than the ground wire to prevent the battery from 
shorting.  During implantation, the exposed wires are taped such that they do not short if 
they are touching a metal surface.  The waterproofing procedure has also been improved 
in this version of the circuit to include potting compound that ensures that no moisture 
causes degradation of the signals or the battery life.  The method for permanently 
attaching the catheter from version 2 and potting the circuit in this version have made the 
implant more robust, but have limited it to single use. 
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Chapter 4: Volume Calibration  
4.1. OVERVIEW 
Accurate calibration of the admittance channel is both important and non-trivial. 
Figure 23 illustrates the physical error sources for the volume channel and Figure 24 
provides a flowchart for removing these errors.  Briefly, the first calibration step is to 
determine the phase offset and gain of the analog circuitry in the implant using resistive 
and capacitive test loads.  The next step is to determine the permittivity error for the 
catheter with saline test loads.  The final step is to determine an appropriate sigma-
epsilon ratio such that the absolute volumes calculated with Wei’s equation correspond to 
ultrasound measurements.  Each of these steps is explained in detail in the following 
sections.         
 



















Figure 24: Implant Calibration Flowchart 
4.2 INSTRUMENT CALIBRATION 
The goal for calibration of the circuitry is to determine the phase delay and gain 
of the admittance measurement block.  This phase delay is a result of analog filtering and 
current source output to ADC input delay in the MCU, and is partially affected by the 
variable load.  The load affects the location of a system pole located roughly one decade 
above 20kHz.  This pole is high enough in frequency that the effects on the magnitude 
response are negligible, but phase response is dynamic within ±1 decade of the 3dB 
corner frequency.  The phase shift at 20kHz is only a few degrees, but ratios of real to 





1. Circuit Calibration: 
•     Performed on circuit only, using test connector. 






2. Remove Probe Capacitance: 
• Performed with real catheter (ready to implant) 
• Data needed: Saline Sweep (bench) 
• Imaginary probe error estimated by linear fit to 
imaginary signal vs. real signal in saline. 
• 𝐼𝑚𝑝ℎ𝑦𝑠   𝐼𝑚𝑏𝑢𝑙𝑘  (𝑎𝑅𝑒𝑚𝑒𝑎𝑠  𝑏) 
Blood Conductance 
3. Remove Muscle Signal: 
• Data needed: sigma-epsilon ratio (numerical search) 





4. Convert to Volume: 
• Data needed: Stroke Volume , EDV -- ESV (ultrasound). 









phase errors translate to large errors in the imaginary component, and subsequent 
uncertainty the removal of the muscle signal.   
A virtual testbench for the admittance measurement circuitry was created in 
National Instruments’ Multisim. This testbench included spice models for the active 
circuit elements (amplifiers) and ideal models for the passive components.  To investigate 
the effects of load-dependent pole movement in the circuitry, an ideal resistor 
representing the test load was swept from 200 to 2000Ω.  The modeled response is 
compared to the response measured from a physical circuit in Figure 25.  A constant 
phase angle was subtracted from the measured data to account for the MCU current 
source output to ADC input delay which is not present in the model.  The model matches 
the measured data well. 
 
Figure 25:  Uncorrected Resistor Sweep 
 To better illustrate the effects of load-dependent pole movement, a secondary 
constant phase angle was subtracted from the model and measurement (same angle 






Resistor Sweep: Real Z
























Resistor Sweep: Imag Z























subtracted from both data sets) to account for filtering not associated with the load.  The 
non-zero imaginary impedance shown in Figure 26 indicates that a constant phase angle 
subtraction is not sufficient to correct for the phase error in the system.  This result is not 
ideal and could be identified as an area for improvement for future iterations of the 
circuit.   
 
Figure 26: Resistor Sweep After Constant Phase Angle Subtraction 
To correct for load-dependent phase error, an interpolation method was used.  
Using the real impedance (resistance) to phase error relation measured in the resistor 
sweep as a lookup table, interpolated values for phase offset were subtracted on a point 
by point basis for all data sets associated with a given implant circuit.  To test this 
calibration method with a load containing an imaginary impedance component, a purely 
capacitive load was swept from 4nF to 30nF in the Multisim testbench and the dynamic 
phase correction was applied.  The real part of impedance for a capacitive load should be 
zero; Figure 27 shows that the phase angle interpolation does leave some real impedance 
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error but the error is much smaller than that remaining from the constant phase error 
subtraction (same constant phase used to generate Figure 26) which doesn’t give the 
correct result. 
 
Figure 27: Capacitor Sweep 
4.3 PROBE CALIBRATION 
A saline calibration is used to determine the permittivity error contributed by the 
catheter.  This error is a result of the parallel capacitance between electrode wires in the 
catheter lumen, and the series impedance of the electrode/electrolyte interface. The 
relative permittivity of water is approximately 80 below 100 kHz, so the imaginary 
component that it introduces into the admittivity, j = j2 (20,000 Hz)(80)(8.85e-12) = 
j*0.89 μS/cm at 20 kHz is negligible compared to the real part for the saline solutions 


































































used:  = 1000 to 11000 μS/cm. Correction for parasitic elements in the catheter was 
accomplished by introducing the catheter to a set of saline solutions with variable 
conductance to characterize permittivity error. 
The Multisim model for the catheter is shown in Figure 28.  Each CpXY capacitor 
models parallel capacitance between electrode wires X and Y.  Each of the 4 electrodes 
has an impedance composed of the three elements shown in Figure 29.  The nominal 
values for the electrode impedance elements are generalized from measurements on 
Scisense surface probes with platinum electrodes [13].  In general, the extended model 
for a long wire would include a series inductance.  Previous work has shown that the 
measurement is insensitive to physically reasonable wire inductance values, so these 
elements were neglected [14].   
 




Figure 29: Electrode Impedance Model 
Assuming equal electrode impedances and equal parallel capacitance between any 
two wires, the Multisim model for the catheter was inserted into the same testbench used 
to perform the resistor calibration. The dominant load resistor (Rload23) was swept 
through the values (1/1000μS, 1/2000μS, 1/3000μS, 1/6000μS, 1/8000μS, and 
1/11000μS).  Phase correction from the resistor sweep was applied to these data.  The 
ImY to ReY relation from the model is compared to the same sweep of saline 
conductances for three separate implants in Figure 30.  In this figure, each implant sweep 
is represented by a blue line.  This data is bounded by two red lines representing the 
modeled saline sweep output with a 10pF (top) and 70pF (bottom) probe capacitance 
values.    Previous work determined that interwire capacitances for similar probes is 
about 50 pF, so the saline sweep data measured from the implant is reasonable [13].  The 
saline sweep points from each implant are used in a lookup table to interpolate load 
dependent probe error in the imaginary component of admittance.  This error is 




Figure 30: Saline Sweeps 
4.3.1 Limitations of the Saline Calibration Method 
 The modeled results for the saline calibration presented above assume that 
electrode impedance is constant for varying saline concentrations.  This may not be a 
valid assumption.  Consider the physical basis for RS, RP, and CP in the electrode model.  
CP represents the electrode/electrolyte interface capacitance, RP represents the charge 
transfer resistance, and Rs represents the solution resistance.  A modeling study presented 
in [15] provides insight into how these circuit elements change with saline conductance.  
In general, the model suggests that each element decreases in magnitude with increasing 
solution conductivity. 
4.3.1.1 Interface Capacitance, CP 
  CP [F] in this model is a simplification of a constant phase angle impedance ZCPA 
that is dependent on the degree of inhomogeneity at the electrode/electrolyte surface 
according to ( 18 ).  In ( 18 ) Q describes the magnitude of the impedivity of ZCPA, and n 

















] Cp = 10pF 
Cp = 70pF  
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characterizes inhomogeneity where 0≤n≤1 and n = 1 for a pure capacitor.  Frequency 
sweeps of the electrode response are required to determine n. 
     ( )  
 
(   ) 
 ( 18 ) 
A theoretical value for the area-dependent interface capacitance, CI [F/m
2
], can be 
derived from the Gouy-Chapman-Stern model, where the total interface capacitance is 
given as the series combination of the double layer capacitance CH [F/m
2
] (also called 
Helmholz capacitance) and the diffuse layer capacitance CG [F/m
2
] (also called Gouy-
Chapman capacitance).  The formulas for the Helmholz and Gouy-Chapman capacitances 
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 ( 19 ) 
Here, dOHP is the thickness of the double layer [m], ε0 the permittivity of free space [F/m], 
εr the relative permittivity of the double layer, z the charge of the ionic species, ϕ0 the 
applied electrode potential [V], Ut the thermal voltage [V], and LD the Debye length [m] 
specified as, 
    √
 0    
  0   
 
( 20 ) 
where n
0 
is the ionic concentration of the solution [m
-3
] and q is the elementary charge 
[15].  From these formulas we see that at the very least the Gouy-Chapman component of 
the interface capacitance is proportional to 1/√n
0
, and so would change with the saline 
conductivity. 
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4.3.1.2 Charge Transfer Resistance, RP 




], is dependent on the 
equilibrium exchange current density, J0 [A/m
2
], which is a measure of the equal but 
opposite reduction/oxidation currents flowing across the electrode/electrolyte interface 
according to ( 21 ). 
    
  
 0  
 ( 21 ) 
Here, R is the universal gas constant [J/mol-K], T is temperature [K], z is the number of 
electrons in the redox reaction, F is Faraday’s constant [C/mol], and J0 is the equilibrium 
exchange current density which is dependent on the concentration of electron-acceptor 
ions at the interface, cA [mol/m
2
], the reduction reaction rate constant, kc [s
-1
], the 
symmetry factor β, and the equilibrium potential, Δϕ0 [V] as described by ( 22 ). 
  0        
(     0)
   
( 22 ) 
Assuming that the concentration of ions near the electrode/electrolyte is proportional to 
saline conductivity, RP would be inversely proportional to saline conductivity.  
4.3.1.3 Solution Resistance, RS 
 Considering that the RS [Ω] component in the electrode model is intended to 
characterize the solution resistance, it is clear that this value will change with saline 
conductivity.  In general, 




( 23 ) 
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where α is the solution conductivity [S/m] and FG is the geometrical form factor [m
-1
] for 
the electrode (ln4/πl for square electrodes and 1/4r for round electrodes).  
 Complex characterization of the electrode impedances for the Scisense tetrapolar 
rat catheter is beyond the scope of this design project.  But the equations above provide a 
framework for re-considering the saline calibration in future studies.  Equations for RS, 
RP, and CP from [15] suggests that the impedance of each element decreases with 
increasing solution conductivity.   
4.4 SIGMA-EPSILON RATIO OPTIMIZATION 
These rat experiments were performed closed-chest, making a direct measurement 
of the sigma/epsilon ratio of the heart muscle impossible.  However, this ratio is an 
important parameter in the admittance to volume conversion as it determines what 
portion of the real part of admittance is subtracted as muscle conductance (see equation ( 
6 )).  Wei’s equation uses stroke volume determined from ultrasound (EDV-ESV = SV) 
to derive calibrated volume from blood conductance, Gb, such that the calculated SV 
matches the measured SV.  However, absolute volume is a function of the sigma-epsilon 
ratio.  A closed form solution of Wei’s equation as a function of sigma-epsilon ratio is 
difficult to derive because the non-linear correction factor, γ, is the larger solution to a 
quadratic equation that depends on Gb_es and Gb_ed, numbers that are dependent on the 
sigma-epsilon ratio as shown in equations ( 24 ) and ( 25 ). Therefore, numerical methods 
were used to find a value for the sigma-epsilon ratio that minimized the error between 
measured (ultrasound) and calculated EDV and ESV. 
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) ( 24 ) 





   
) ( 25 ) 
Ges and Ged are the real components of physiological admittance [S] (lumped blood and 
heart muscle) at end systole and end diastole, respectively.  Bes and Bed are the imaginary 
components of physiological admittance [S]. 
To get an average value for Ges, Ged, Bes, and Bed for the admittance calibration 
trace (recorded during ultrasound volume measurement), a peak-finding algorithm was 
implemented in MATLAB.  Figure 31 below shows a typical output for this algorithm. 
 
Figure 31: Output of Peak Finding Algorithm. 
In general, the real part of admittance is maximized at end diastole when the 
blood volume in the LV is largest, and the imaginary part is maximized at end systole 
when the muscle is closest to the catheter.  So, the positive real Y peaks were averaged to 
find Ged, the positive imaginary Y peaks were averaged to find Bes, and vice versa for the 




































negative peaks.  These four parameters are passed as constants to the sigma-epsilon 
search algorithm and used to determine sigma-epsilon dependent values for Gb_ed and 
Gb_es.  For each sigma-epsilon number, Wei’s equation is used to calculate volume, the 
peak-finding algorithm is used to determine the average calculated EDV (positive peaks) 
and ESV (negative peaks), and an error measure is calculated by, 
    (               )
  (               )
  
( 26 ) 
The sigma-epsilon ratio for which this error term is minimized is recorded and 
used for all further processing of the data for this implant.  An example output of this 
algorithm showing calibrated volume is given in Figure 32.  The dotted lines represent 
EDV (red) and ESV (blue) measured by ultrasound, and the black trace is calculated 
volume. The PV loops resulting from this calibration method are shown in Figure 33.  
Again, the dotted lines represent EDV and ESV from ultrasound.  
 
 
Figure 32: Calibrated Volume After Sigma-Epsilon Ratio Search 



























Figure 33: PV Loops After Sigma-Epsilon Ratio Search Algorithm 
 
Table 4: Numerically Determined Best-fit Sigma-Epsilon Ratios 
Experiment Best-fit σ/ε 
Rat 3 0.54 x 10
6
 
Rat 4 1.04 x 10
6
 
Rat 5 1.34 x 10
6
 
Rat 6 0.21 x 10
6
 
Rat 7 0.63 x 10
6
 
Rat 8 NA 




Table 4 reports the best-fit sigma-epsilon ratio for each of the 6 experiments.  As 
a reference point, surface probe measurements from Raghavan’s 2004 rat experiments 
specify an average sigma-epsilon ratio of 1.40 x 10
6 
[10].  The Scisense Advantage 
system uses sigma-epsilon value of 0.88 x 10
6
, which is consistent with the data Table 4 
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and is derived by a similar empirical optimization method.
 
 Discrepancy in sigma-epsilon 
values from these sources, and the relatively large standard deviation in the optimized 
sigma-epsilon ratios from this work, suggests that there is room for improvement in 
determination of sigma-epsilon ratio.      
In the Gb to volume calculation, blood resistivity, ρblood, is assumed to be a 
constant, literature-derived value.  If this value is incorrect, the optimized value for 
sigma-epsilon ratio will represent overcompensation.  Blood conductivity variation is 






Chapter 5: In-vivo Experiments 
5.1 IMPLANTATION PROCEDURE SUMMARY 
All implantation procedures were conducted at the University of Texas Health 
Science Center San Antonio (UTHSCSA) by a veterinary technician.  To begin, a rat is 
anesthetized with 1-2% isoflourane and the area between the shoulder blades is shaved.  
The rat is placed on a heated surgery stage which records body temperature and EKG 
signals during ultrasound.  A pre-surgery ultrasound is conducted to determine the 
original volume of the heart.  This step also allows the veterinarian to determine if the 
heart has any inherent defects.  A vertical midline cervical incision in made to expose the 
right common carotid artery.  The rat is positioned dorsal side up and another vertical 
incision is made between the shoulder blades.  A metal tube is used to guide the catheter 
under the skin on the right shoulder from the dorsal to the ventral incision.  The rat is 
again turned ventral side up.  The carotid artery is opened and the catheter is inserted.  
The veterinarian guides the catheter down the carotid artery and into the left ventricle of 
the heart.  The pressure signal from the implant is used to determine when the catheter 
reaches the heart, as this event causes the pressure trace to change from a distinct aortic, 
to ventricular pattern.  Ultrasound and PV loop shape are used to verify correct 
positioning of the catheter in the ventricle.  The admittance data collected during this 
ultrasound measurement is used to correlate minimum and maximum blood conductance 
values to end systolic and end diastolic volume (ESV and EDV), respectively.  The 
catheter position is then stabilized with sutures near the entry site of the carotid artery.  
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The ventral incision is closed and the rat is turned ventral side down.  The circuit is then 
positioned underneath the skin between the shoulder blades and the dorsal incision is 
closed.  During surgery, the circuit transmits with minimal cycle delay (cycle delay set to 
zero gives one epoch every 10 seconds) and so consumes battery power.  The battery is 
recharged while the rat is still under anesthesia to improve implant lifetime.  The 
implantation procedure lasts about 2-3 hours.   
5.2 IMPLANT TIMELINES 
 
Figure 34: Implant Timelines 
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There were 6 full implant procedures.  Figure 34 represents schematically the 
timeline of each implant, indicating the time for which valid pressure and volume data 
was collected.  Experiment numbers are given on the left and implant ID numbers on the 
right.  Note that the longest period for which valid data was collected was about ten days.  
Implantation day loops for each implant are shown in Figure 35  Let us examine the 
performance of each implant.  
 
Figure 35: PV Loops on Implantation Day 
5.2.1 Rat 3, Implant 0 
Rat 3 was the first full-implant experiment, and utilized the version 1 device with 

































































































collected on day 1, the implantation day, but the battery was drained by day 2.  A 
recharge procedure which included disconnecting the catheter, connecting a battery 
charger, and reconnecting the catheter in-vivo failed due to the small size of the catheter 
and the slippery silicone coating.  The circuit was removed during this attempted 
recharge procedure, but the catheter was left in place to investigate tissue interaction 
effects on catheters implanted long term.   
5.2.2 Rat 4, Implant S2 
Implant S2 and S4 were the last implants used in experiments that included a code 
bug that allowed excess current consumption in sleep mode.  The sleep current of implant 
S2 was measured at ~30μA before implantation and ~250μA during failure analysis after 
retrieval.  Thus, implant S2 had a very short (about 1 day) battery life.  Fortunately, the 
version 2 device used for Rat 4 was more easily rechargeable.  This allowed us to collect 
admittance data over a 10-day time span.  The pressure signal stopped giving valid data 
after day 1.  Dissection of the circuit after implantation suggests that a pressure wire was 
broken near the tip of the catheter.  The experiment was stopped when the rat chewed or 
scratched off the battery connector, making recharging impossible.   
5.2.3 Rat 5, Implant S4 
Despite the code bug present in version 2 of the circuit, Implant S4 lasted 23 days 
on a single charge.  This implant provided the most complete data set, as the catheter was 
intact for 11 days.  Valid pressure data was measured over these 11 days, but on day 4 the 
catheter became lodged in the papillary muscles (verified through ultrasound), causing 
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the volume signal to become non-physiological.  From days 6-14 the pressure and 
admittance signals seem to indicate that wires within the catheter are breaking, causing 
“noisy” random outputs. 
5.2.4 Rat 6, Implant S5 
The experiment for implant S5 lasted 20 days.  Pressure and volume signals were 
valid out to day 3, at which point the signals indicate connections to the catheter were 
compromised.  The subject was sacrificed at the three week ultrasound measurement 
when it was discovered that the catheter had perforated the septum of the heart and 
moved from the left ventricle to the right ventricle.  The battery on this implant lasted 
only 8 days on its initial charge (possibly due to contacting charging leads), and was 
recharged on day 17.  This accounts for the lapse in data collection.   
5.2.5 Rat 7, Implant S1 
The Rat 7 experiment had a similar outcome to the Rat 5 experiment, though on a 
shorter time scale.  Pressure signals were continuously valid out to day 3, and intermittent 
after that point until day 5.  The admittance signals suggest that late in day 1 the catheter 
became ill-positioned (possibly lodged in the papillary muscles as in Rat 5), causing the 
muscle signal to dominate the measured bulk admittance of the heart.  Interestingly, after 
this event, there is one more valid epoch in day 1 and one in day 2, suggesting that the 
catheter became dislodged for short periods.  On day 5 the pressure and admittance 
signals clearly show that there is a bad connection.  
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5.2.6 Rat 8, Implant S8 
Experiment 8 did not produce viable PV data because the measured susceptance 
(ImY component) was negative both before and after phase calibration.  There may have 
been a physical defect in the circuit that caused the resistor/capacitor/saline calibration to 
become invalid. 
5.2.7 Failure Analysis Summary 
These 6 implant studies suggest that there is still room to improve the robustness 
of the implant in-vivo.  The failure point for experiments 3 and 4 was short battery life 
and an inability to charge the battery.  With an improved battery charging interface, 
experiments 5 and 7 failed to produce valid PV loops after a few days due to poor 
positioning of the catheter in the ventricle, despite correct functionality of the circuit.  
Degradation and eventual loss of signal was observed in experiments 5, 6, and 7, and is 
thought to be caused by kinking or breaking of wires within the catheter.  
5.2.8 Animal Health 
One of the primary design objectives of this project was to improve upon previous 
designs by making the implant circuitry smaller and lighter so as not to be a hindrance to 
the animal. Average implant weight was 8g and average volume was 5mL.  Observation 
of these 6 rats suggests that the bulk of the implant between the shoulder blades does not 
cause apparent weakening of the animal.  However, ultrasound data indicates a trend 
toward heart enlargement over time (Table 5).     
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Table 5: Heart Volume Over Time From 2D Echo 
Group n LVEDV LVESV LV EF% 
Pre implant 6.00 456.51±120.08 128.49±40.99 71.15±9.37 
post implant 6.00 457.43±177.88 137.84±49.92 68.60±10.97 
week 1 6.00 548±162.69 201.82±92.25 64.01±8.38 
week 2 6.00 657.36±181.00 269.14±98.46 59.15±7.11 
week 3 5.00 700.34±117.65 276.50±86.81 59.90±12.37 
 
5.3 VOLUME OVER TIME 
Experiment 4 provided valid admittance data for the longest period of time, 10 
days.  As previously mentioned, excess leakage current during sleep mode limited the 
lifetime of the implant to about 1 day per charge, so data was only collected on 4 of the 
10 days (for each time the battery was recharged).  The traces for Gb and Gm on these four 
days are given in Figure 36.  Individual epochs are demarcated by shaded/un-shaded 
regions.  Data was collected every 2 hours for this implant. 
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Figure 36: Blood (blue) and Muscle (red) Conductance Traces Over 10 Days 
 
These plots show changes in average blood and muscle conductances (Gm and Gb) 
both on shorter (epoch to epoch, 2 hour) and longer (day to day) time scales.  These 
deviations result in marked changes in calculated volume over time, as shown in Figure 
37.   
PV loops from implantation day were used to choose an appropriate sigma-
epsilon for the remaining data set (Figure 38, left pane).  Ultrasound verified that the 
catheter was in a centered position (Figure 38, right pane).    Possible sources of error 





















































include changes in blood conductivity over time (examined in Section 5.3.1) and changes 
in catheter position (examined in Section 5.3.2).  
 
Figure 37: Volume Measured by Ultrasound and Experimental Implant 
 
Figure 38: Catheter Position and PV Loops During Implantation for Rat 4 
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γ = 0.0033 α = 0.40 
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In Figure 37, calculated volume from days 1, 3, 9, and 10 is superimposed over 
the ultrasound measured volume.  Two methods of Gb to volume conversion are shown.  
In the left pane, volume was calculated using Wei’s equation (8).  In the right pane, 
volume was calculated using Baan’s linear conductance to volume equation (7). For both 
the linear (Baan) and non-linear (Wei) volume calculations, raw PY data from the 
implant was calibrated as explained in Chapter 4. 
5.3.1 Changes in Blood Resistivity Over Time 
Blood resistivity is assumed to be constant for the analysis described in this 
report.  However, there is evidence to suggest that this may not be a valid assumption.  
Uemura’s rat implant experiments in 2004 used a catheter that included a secondary 
tetrapolar electrode set to measure blood resistivity in the ambulatory rat.  Over 6 days, 
ρblood was observed to span the range 175-275 Ω-cm [9].  A ρblood value of 167 Ω-cm 
measured in previous experiments was used for all analyses presented in this report.  
Changes in blood resistivity over time result in volume errors since calculated volume is 
nearly linearly proportional to ρblood (see equations ( 7 ) and ( 9 )).   
5.3.2 Catheter Positioning Error 
An experiment was conducted to investigate the sensitivity of the admittance 
measurements to deviations in catheter position.  Research has shown that the flesh of 
winter squash may be used as a reasonable analogy to human tissue, having a sigma-
epsilon ratio around 0.31 x 10
6
 [16].  A 1/2" hole was drilled in the flesh of an acorn 
squash to simulate the blood volume and filled with 2 mL of 3000 μS/cm saline solution.  
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To determine sensitivity to catheter position, a secured caliper was used to 
simultaneously displace the catheter from the centered position, and measure the 
displacement in mils (1/1000
th




Figure 39: Squash Cuvette Catheter Position Experiment 
Since a static cuvette has no stroke volume, the linear volume conversion 
equation ( 7 ) was used to determine calculated volume.  The result of the experiment 
(n=3 trials) is given in Figure 40.  The volume measured at positions representing 50% 
displacement and greater from the center show marked error in measured volume.  Note 
that the magnitudes of the real and imaginary components are comparable to those 
measured in the rat, and that ReY decreases and ImY increases as the catheter moves 
closer to the cuvette wall as expected. 
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Figure 40: Volume vs. Catheter Position 
With this, consider the volume traces measured on days 9 and 10 in Rat 4.  These 
traces were chosen for analysis because they are the most representative data collected 
for admittance after “long term” implantation, when the physiological state and implant 
position are assumed to have stabilized.  Figure 41 gives the ReY, ImY, and calculated 
volume traces on these days.  In these traces, the average value of ImY is fairly dynamic 
across epochs.  This could either indicate that catheter position is changing, or true 
volume is changing.  Relative positive changes in ImY and negative changes in ReY as 
observed in the squash cuvette for catheter displacement towards the wall are also seen in 
Rat 4, especially in epochs like day 10, epoch 6.  This effect causes the calculated total 
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total volume of the heart or the blood conductivity has changed enough in 2 hours to 
cause calculated volume to change by 100% as suggested by paired epochs like day 10, 
epochs 4 and 5.  Therefore, we may conclude that catheter displacement is causing 
significant volume error.   
Note that for this analysis, ultrasound data from Rat 4, day 7 was used to 
recalibrate this data such that the epoch with the lowest average ImY and highest average 
ReY produced correct values for EDV and ESV.  In this recalibration, sigma-epsilon ratio 




.  As suggested by the squash cuvette experiment, 
this calibration epoch should represent measurements from a centered catheter.   
 










































































5.3.3 Admittance Drift Due to Biological Wear 
There has been some concern in the past about admittance drift over time due to 
tissue reaction to the catheter.  It was hypothesized that fibrotic growth on the 
source/measurement electrodes of the catheter may increase the electrode impedance and 
reduce the current density in the blood pool, thereby changing the admittance to volume 
calibration.  To investigate tissue effects on the catheter over time, an inactive catheter 
was left in the heart after the failure of Implant 0 (see Figure 34).  The rat lived for 5 
months with the inactive catheter.  The heart was dissected post-mortem to examine the 
catheter.  No fibrotic growth was observed on the catheter as shown in Figure 42.  This 
one experiment does not comprise a representative set, but suggests that the Scisense 
catheter material may be appropriate for long term implantation.  At the time of writing, 
two more rats with inactive catheters are under observation. 
 
Figure 42: Catheter After 5 Months in the Heart 
 
5.4 PRESSURE OVER TIME 
Drift in absolute pressure is a concern for a PV monitoring device as changes in 
end diastolic pressure (EDV) may indicate pathology.  In an optimal use case, the lumen 
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of the Scisense PV catheter should be vented to atmospheric pressure so that the 
measured pressure is atmosphere relative.  However, venting to the atmosphere is not 
possible in a fully implanted system, and the lumen of the catheter is sealed during 
fabrication of the implant.  Since LV pressure changes with atmospheric pressure and the 
catheter reference pressure (lumen pressure) does not, barometric pressure should be 
monitored during data collection.   
Experiment 5 (implant S4) provided 11 continuous days of pressure 
measurements, collected at a 1 epoch/hour sampling rate.  The minimums of this pressure 
trace (Figure 43) were recorded and assumed to represent LV pressure at end diastole.  
Figure 44 shows the EDP drift over 11 days.  Two additional traces are superimposed for 
comparison.  Deviation from the mean barometric pressure in San Antonio, TX (reported 
from [17]) over the 11 days of data collection is shown in red.  Pressure drift from a 
sealed catheter submerged in an open container of saline over a different set of 11 
consecutive days in Austin, TX is shown in green.  The average EDP reported from the 
implant was 0±6 mmHg, the average deviation in barometric pressure in San Antonio 
over the same 11 days was 0.0±1.8 mmHg, and the standard deviation in pressure from 
the sealed catheter submerged in saline was 2.9 mmHg.  The standard deviation in 
measured EDP is more than twice the standard deviation in barometric pressure or 
pressure drift in the sealed catheter.  This excess deviation in EDP could be the result of 
physiological variation, or physical forces (bending) on the sealed catheter lumen.   
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Figure 43: Location of End Diastolic Pressure Points (blue) 
 
 
Figure 44: End Diastolic Pressure Drift 
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Sealed Catheter Bench Test
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Chapter 6: Conclusion 
6.1 IMPLANT PERFORMANCE 
In accordance with the design objectives, an 8g, 5cm
3
 device has been created that 
is capable of measuring PV data from the ambulatory rat heart for >2 months. Acute 
functionality of the experimental implant has been verified in six in-vivo rat studies.  In 
five of the six studies, ambulatory PV loops were recorded on implantation day.  In the 
sixth study (experiment 8), reasonable raw impedance data was available but could not be 
converted to volume due to inaccurate calibration data.  The typical timeframe for which 
valid pressure and volume data was transmitted was 2-3 days.  One implant (experiment 
5) transmitted valid pressure data out to day 11, another implant (experiment 4) 
transmitted valid volume data out to day 10.  Bench testing data indicate that the implant 
is able to transmit 43 times per day for 2 months.   Later experiments (6, 7, and 8) 
indicate that the limiting factor for implant lifetime at present is the breakage of wires 
within the catheter.  Beyond this, changes in catheter position and blood resistivity over 
time affect the accuracy of calculated volume.  Long term health of the animal is also a 
concern for future experiments.  Observation indicates that the bulk of the implant 
between the shoulder blades is not a hindrance to the animal, but the continual presence 
of the catheter in the aortic valve appears to cause thickening of the valve flaps, 
subsequent aortic insufficiency, and enlargement of the heart over time. 
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6.2 FUTURE DIRECTIONS 
The implant circuit may find future uses with similar transducers.  The interface 
used to connect the Scisense PV catheter to the circuit it readily adaptable to new probes, 
and different catheters/electrode configurations may prove more robust in-vivo.  
Changing a few components in the admittance measurement circuit would allow for 
volume measurements to be made in larger animals as well.   
Some care should be given to the effects of catheter parasitic elements and 
electrode interface impedances in future work.  Calibration of the system could be 
improved by the development of a better circuit model for the probe/instrument system 









- Small board mount 
- Soldering iron and solder 
- Bending mold 
Materials 
- Kapton tape 
- Electrical tape 
- General purpose superglue 
- Potting compound: 3M DP-270 Epoxy Potting Compound 
- Silicone: Dow Corning 734 Flowable Sealant 
 
Procedure: 
1.  Cut a 20.5 cm length of catheter. 
2. Tape the catheter around the bending mold using Kapton tape as shown in Figure 
1. Leave 1 cm of catheter after the downward slope on the cut side.  Some of this 
length will be stripped away to expose the catheter wires.   
3. Set the heatgun temperature to 167 C and the airflow to 3. 
4. Use a test piece of catheter (the extra cut from the original length) to get a feel for 
how close you need hold the heat gun to the catheter to cause it to bend.  This 
distance should be about one inch. 
5. Heat the catheter on the mold.  Make swift passes about an inch away from the 
catheter.  Avoid heating any area for too long. 
6. Under the microscope, use a scalpel to strip about ¼ inch from the cut end of the 
catheter.  About ¼ inch back from the cut end, slide the scalpel into the catheter 
and up to the cut end.  See Figure 2.  You may want to test the scalpel on the test 
catheter material used before.  If it is not sharp enough, get a new blade!   
7. There should be 7 wires inside the catheter.  Once the wires are exposed, gently 
move them aside and cut off the excess empty catheter.  At this point, the catheter 
should appear as shown in Figure 3. 
8. Set the circuit in the small circuit holder with the analog side up (side without 
MCU).  Using superglue, mount the catheter to the circuit as shown in Figure 4.  
Be careful not to get superglue too close to the catheter pads or on the catheter 
wires.  Hold the catheter in place with tweezers until the glue sets. 
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9. Gently tape the sensor end of the catheter down to the table using Kapton tape so 
that you will be able to probe the electrodes with the voltmeter. 
10. Find the red wire.  Using tweezers, guide it into the R1 hole and solder it down. 
11. For each other wire: 
a. Separate the wire from the others. 
b. Tin the end of the wire with solder (about 1-2 mm at the end). 
c. Use one voltmeter probe to pin the tinned wire to the circuit and the other 
probe to test for continuity.  
d. If the wire is continuous with an electrode, guide it into the appropriate 
hole. 
e. If the wire is not connected to any of the electrode rings, it may be a 
pressure wire.  Measure the resistance against the soldered R1 wire.  If it is 
2 kΩ, then the wire is R2.  If it is 1 kΩ, then the wire is GND.  Guide the 
wire into the appropriate hole. 
12. Some tips on soldering the wires: 
a. To tin the wire, get a blob of solder on the iron away from the circuit and 
slide the catheter wire into it.  If you touch solder to the iron around the 
catheter wires, steam and resin can cause the wires to stick together, or 
worse yet, contact! 
b. I solder the pressure wires to the board from the admittance side and the 
electrode wires from the MCU side of the circuit.  Again, this prevents 
steam and resin from sticking the wires together. 
13. After soldering the wires down, the circuit should appear as shown in Figure 5. 
14. Once all wires are soldered, quickly test the catheter and circuit for functionality 
in saline and in the pressure chamber.  Be very careful not to touch the soldered 
wires.  Mechanical stress on the wires can cause them to break. 
15. Mix up a small amount of potting compound.  Gently cover the catheter wires 
with potting compound to stabilize them.  I let the potting compound drip onto the 
wires to avoid pressing on the wires. 
16. Obtain a functional battery.  Cut the battery wires to be as long as the top of the 
battery and solder them to the circuit as shown in Figure 6. 
17. Cover the remainder of the admittance side of the circuit with potting compound.   
18. Before the potting compound dries, fold the battery against the circuit as shown in 
Figure 7. 
19. Once the potting compound is dry, attach 2 wires to the battery terminals from the 
MCU side of the circuit.  These wires will be used to charge the battery after 
implantation. 
20. Cover the MCU side of the circuit in potting compound. 
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21. Once the potting compound has cured, carefully cover the circuit in a thin layer of 
electrical tape (Figure 8).  Be cautious not to kink the catheter. 
22. Apply a thin layer of silicone to the circuit but not the catheter. 
23. Once the silicon on the circuit has cured, lay a piece of wax paper between the 
circuit and the catheter.   
24. Apply silicone along the bent portion of the catheter. Don’t worry about getting it 
perfect, the silicone can be trimmed later. 







Sloped Side Flat Side 
Figure 45: Catheter on Bending Mold 
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Figure 46: Exposing Catheter Wires 
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Figure 47: Formed Catheter With 7 Wires Exposed 
 




Figure 49: Catheter Wires Soldered to the Circuit 
 
Figure 50: Potting Compound Applied and Battery Attached 
 77 
 
Figure 51: Battery Mounted Against the Circuit Using Potting Compound 
 
Figure 52: Circuit Covered in Electrical Tape 
 78 
 
Figure 53: Completed Implant  
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Appendix B: Rat 3 Data Set Summary 
 
 
Figure 54: Volume Calibration, Rat 3 
Table 6: Calibration Constants, Rat 3 
Admittance Magnitude Gain 1.67 
Pressure Gain -0.40 
Pressure Offset -370 
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Appendix C: Rat 4 Data Set Summary 
 
 
Figure 55: Volume Calibration, Rat 4 
Table 7: Calibration Constants, Rat 4 
Admittance Magnitude Gain 1.68 
Pressure Gain -0.43 
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Figure 56: Pressure Data, Rat 4 
 






































































Figure 57: Admittance Data, Rat 3 
  





















































Appendix D:  Rat 5 Data Set Summary 
  
Figure 58: Volume Calibration, Rat 5 
Table 8: Calibration Constants, Rat 5 
Admittance Magnitude Gain 1.675 
Pressure Gain -0.43 
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Figure 59: Pressure Data, Rat 5 
 
















































































































































































































































Figure 60: Volume Data, Rat 5 
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Appendix E.  Rat 6 Data Set Summary 
 
 
Figure 62: Volume Calibration, Rat 6 
Table 9: Calibration Constants, Rat 6 
Admittance Magnitude Gain 1.685 
Pressure Gain 0.417 
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Figure 63: Pressure Data, Rat 6 
 
 















































































































































































































Figure 64: Volume Data, Rat 6 













































































































Appendix F.  Rat 7 Data Set Summary 
 
Figure 65: Volume Calibration, Rat 7 
Table 10: Calibration Constants, Rat 7 
Admittance Magnitude Gain 1.685 
Pressure Gain 0.417 
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Figure 68: PV Data, Rat 7 
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